Sections
Shows
Glaxosmithkline
Recent Highlights
All Stories for Glaxosmithkline
Indian generic drugmakers may face supply shortages from China if coronavirus drags on: Report
•An important supplier of generic drugs to the world, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.
Researchers find a compound that can halt growth of parasite that causes malaria
•Apparently, a compound developed by GlaxoSmithKline can eliminate the mosquito-borne parasite in all the stages of its lifecycle.
CCI approves GlaxoSmithKline, Pfizer consumer healthcare joint venture
•The Competition Commission on Friday said it has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer
Pfizer to shut down two plants in India citing unviability; decision leaves about 1,700 employees in lurch
Fp Staff •Pfizer will soon shut down its plants in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing lack of viability.
GSK and Pfizer to combine consumer health businesses; British drugmaker plans to split into two businesses
•GSK said the deal laid the foundation for the creation of two new UK-based global companies focused on pharmaceuticals/vaccines and consumer healthcare
Unilever CEO Paul Polman steps down after headquarters move fiasco, replaced by insider Alan Jope
Fp Staff •A UK investor revolt forced Polman and the Unilever board to scrap a plan in October to move the headquarters of the dual-listed company to the Netherlands
GSK Consumer Healthcare says it is considering potential transaction of nutrition business; Unilever confirms development
•Hindustan Unilever, the Indian arm of Unilever, confirmed that the company was in the race to acquire GlaxoSmithKline Plc's consumer healthcare nutrition products
Unilever emerges as leading bidder in tight contest for GlaxoSmithKline's Horlicks nutrition business
•GSK’s assets, which include the popular malt-based drinks Horlicks and Boost, is likely to fetch less than $4 billion, said people close the deal
Coca-Cola in race to buy Horlicks from GlaxoSmithKline, value of transaction could be around $3.9 billion
•Besides Coca-Cola, several global FMCG makers as Nestle, Kraft Heinz are in the race to acquire Horlicks from GSK
Glenmark Pharma pushes first generic product in Europe with asthma drug in Denmark
•Glenmark said it has already received National Marketing Authorizations for the product in Sweden, Finland, Norway and Iceland.